Jazz Pharmaceuticals plc buy Barclays PLC
Start price
29.01.24
/
50%
€116.60
Target price
29.01.25
€217.33
Performance (%)
-12.69%
Price
10.05.24
€101.80
Summary
This prediction is currently active. The price of Jazz Pharmaceuticals plc has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.69%. This prediction currently runs until 29.01.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Jazz Pharmaceuticals plc | -0.440% | -0.440% |
iShares Core DAX® | 4.094% | 4.888% |
iShares Nasdaq 100 | 1.424% | -0.445% |
iShares Nikkei 225® | -1.572% | -4.911% |
iShares S&P 500 | 1.822% | 0.776% |
Comments by Barclays_PLC for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target lowered by analysts at Barclays PLC from $240.00 to $235.00. They now have an "overweight" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Barclays_PLC for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€102.25
03.05.24
03.05.24
€185.60
03.05.25
03.05.25
-0.44%
10.05.24
10.05.24
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€109.55
01.03.24
01.03.24
€212.20
01.03.25
01.03.25
-7.07%
10.05.24
10.05.24